Feedback
The current prices are delayed. Login to see live prices.
IPCA Laboratories Ltd.
(IPCALAB)
10123456789,501234567898012345678920123456789.5012345678900123456789
-12.45 (-0.78%)
Updated 16:02 20/12 IST
Add
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
ā¹1,578.00
Today's high
ā¹1,616.4
52 week low
ā¹1,052
52 week high
ā¹1,708.65
Open
ā¹1,607.95
Prev Close
ā¹1,594.95
Volume (shares)
683,300
Total Trading Value
108.98 Cr
Technicals
SMA
Value
Signal
12-SMA
1,545.83
Bullish
20-SMA
1,546.74
Bullish
50-SMA
1,574.73
Bullish
100-SMA
1,491.32
Bullish
200-SMA
1,362.13
Bullish
Valuations
PE Chart
Median PE (M) : 59.06
Current PE is higher than median PE.
PB Chart
Median PB (M) : 4.92
Current PB is higher than median PB.
Fundamentals
Market Cap
ā¹40,148.03 Cr
Enterprise Value
ā¹41,238.69 Cr
No. of Shares
25.37 Cr
P/E Ratio(TTM)
60.72
RoE
8.7%
Debt/Equity
0.22
Revenue vs Profitability (In Cr.)
Mar, 2020Mar, 2021Mar, 2022Mar, 2023Mar, 2024
Revenue
Profit
Margins (%)
Mar, 2020Mar, 2021Mar, 2022Mar, 2023Mar, 2024
Gross Margin
Net Margin
Ratios
Debt/Equity
Mar, 2020Mar, 2021Mar, 2022Mar, 2023Mar, 2024
Debt to Equity
ROE vs ROCE
Mar, 2020Mar, 2021Mar, 2022Mar, 2023Mar, 2024
ROE
ROCE
Shareholding
Shareholding Pattern
Public : 8.65%
FII : 10.83%
Others : 0%
DII : 34.22%
Promoter : 46.3%
Shareholding History
Jun, 2023Sep, 2023Dec, 2023Mar, 2024Jun, 2024Sep, 2024
Peer Comparison
Peer companies
Market Capital (Cr.)
P/E
P/B
Price(ā¹)
SUNPHARMA
433,919.73
39.26
18.4
1,823.3
ABBOTINDIA
60,853.11
0
17.29
29,053.85
GLENMARK
43,523.29
0
1.82
1,540.8
BIOCON
40,334.16
28.03
3.7
350.35
IPCALAB
40,193.09
60.72
5.96
1,594.95
GLAXO
38,700.81
57.12
23.02
2,326.3
AJANTPHARM
35,621.18
40.92
10.14
2,875.7
Discussions
Ā Ā ā¢Ā Ā Dec 20 1:35 AM
Ā Ā ā¢Ā Ā Dec 18 3:18 PM
Ā Ā ā¢Ā Ā Dec 13 4:18 AM
Ā Ā ā¢Ā Ā Nov 19 1:19 PM
Ā Ā ā¢Ā Ā Nov 19 12:30 AM
Sharekhan target on IPCALAB
Date: 14-Nov-24...read more
Ā Ā ā¢Ā Ā Nov 18 12:36 PM
Ā Ā ā¢Ā Ā Nov 16 4:51 AM
Ipca Laboratories - Quarterly Results
Earnings Update...read more
Ā Ā ā¢Ā Ā Nov 13 12:30 AM
Ā Ā ā¢Ā Ā Nov 4 2:20 PM
Ā Ā ā¢Ā Ā Oct 21 4:59 PM
Ā Ā ā¢Ā Ā Oct 16 3:06 PM
Ā Ā ā¢Ā Ā Oct 16 12:30 AM
Motilal Oswal target on IPCALAB
Date: 14-Oct-24...read more
8
13
Ā Ā ā¢Ā Ā Oct 15 6:16 PM
#IPCALAB added 1700 strike put options with stoploss in cash market above 1712 daily closing basis for target 1650/1628 in c
1
Ā Ā ā¢Ā Ā Oct 15 6:00 PM
#IPCALAB yesterday price rejected from resistance zone of 1712 and closed around 1682 so as per our Gann degree formula toda
Ā Ā ā¢Ā Ā Oct 14 3:10 AM
ššššš
TRADE DATE: 14-Oct-24...read more
Ā Ā ā¢Ā Ā Oct 9 4:19 AM
Ā Ā ā¢Ā Ā Oct 9 3:36 AM
Ā Ā ā¢Ā Ā Oct 4 12:30 AM
Sharekhan target on IPCALAB
Date: 30-Sep-24...read more
4
13
Ā Ā ā¢Ā Ā Sep 6 4:34 PM
Ā Ā ā¢Ā Ā Sep 5 3:43 PM
If #IPCALAB today close above 1410 can touch 1473 if close above 1480 can go up to 1900-1960 for short term. This call for e
2
Ā Ā ā¢Ā Ā Sep 5 4:48 AM
Ā Ā ā¢Ā Ā Sep 4 1:26 AM
Ā Ā ā¢Ā Ā Aug 21 12:30 AM
Sharekhan target on IPCALAB
Date: 14-Aug-24...read more
5
10
Ā Ā ā¢Ā Ā Aug 15 4:51 AM
Ipca Laboratories - Quarterly Results
Earnings Update...read more
Ā Ā ā¢Ā Ā Aug 12 12:30 AM
Ā Ā ā¢Ā Ā Aug 11 5:43 AM
Ā Ā ā¢Ā Ā Aug 9 2:22 AM
šØšØ BREAKOUT STOCK šØšØ
....read more
5
6
Ā Ā ā¢Ā Ā Jul 15 1:42 AM
Load More Posts
Frequently Asked Questions (FAQs)
What is the Share Price of IPCA Laboratories Ltd. ?
The share prices are volatile and fluctuate throughout the trading hours. The share price of IPCA Laboratories Ltd. is Rs 1594.95 as of 20 December 2024.
What is the Market Capitalization of IPCA Laboratories Ltd. ?
The current market cap of IPCA Laboratories Ltd. is ā¹40148.03 Cr. Market capitalisation is calculated by multiplying the current share price with the total number of shares.
What are the PE and PB ratios of IPCA Laboratories Ltd.?
IPCA Laboratories Ltd. has a price-to-earnings (PE) ratio of 60.72 and a price-to-book (PB) ratio of 5.99.
What is the 52-week high/low of IPCA Laboratories Ltd.?
The 52-week high of IPCA Laboratories Ltd. is Rs 1708.65 and the 52-week low is Rs 1052
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
Disclaimerā¢Privacyā¢ā¢
FrontPage Ā© 2024